
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Ampulla of Vater
Carcinoma
Neuroendocrine tumors - staging
Reviewer: Hanni Gulwani, M.D. (see Reviewers
page)
Revised: 11 December 2012, last major update August 2012
Copyright: (c) 2003-2012, PathologyOutlines.com, Inc.
Primary tumor (T)
=========================================================================
TX: Primary tumor cannot be assessed
T0: No evidence of primary tumor
T1: Tumor invades lamina propria or submucosa and tumor size 1 cm or less
T2: Tumor invades muscularis propria or tumor size >1 cm
T3: Tumor invades through the muscularis propria into pancreas or retroperitoneum (ampullary or duodenal tumors) or into nonperitonealized tissues
T4: Tumor invades visceral peritoneum (serosa) or invades other organs
● For any T, add (m) for multiple tumors
Regional lymph nodes (N)
=========================================================================
NX: Regional lymph nodes cannot be assessed
N0: No regional lymph node metastasis
N1: Regional lymph node metastasis
Distant Metastasis (M)
=========================================================================
M0: No distant metastasis
M1: Distant metastasis
Anatomic stage / prognostic groups
=========================================================================
Stage I: T1 N0 M0
Stage IIA: T2 N0 M0
Stage IIB: T3 N0 M0
Stage IIIA: T4 N0 M0
Stage IIIB: Any T N1 M0
Stage IV: M1 (any T, any N)
Additional references
=========================================================================
● Virchows Arch 2006;449:395, Staging form
End of Ampulla of Vater > Carcinoma > Neuroendocrine tumors - staging
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other
contact information).